TRADING UPDATES: Valereum invests in Blubird; Hemogenyx raises funds
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
Price | 7.25p on 18-07-2025 | at 18:50:07
---|---|
Change | -0.25p -3.33% |
Buy | 7.50p |
Sell | 7.00p |
Buy / Sell RENX Shares |
Last Trade: | Unknown 2,612.00 at 7.35p |
Day's Volume: | 128,221 |
Last Close: | 7.25p |
Open: | 7.50p |
ISIN: | GB00BYWL4Y04 |
Day's Range | 7.25p - 7.50p |
52wk Range: | 6.50p - 17.50p |
Market Capitalisation: | £24.01m |
VWAP: | 7.281689p |
Shares in Issue: | 331.21m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Renalytix Plc (RENX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Unknown* | 2,612 | 7.35p | Negotiated Trade |
16:35:00 - 18-Jul-25 |
Unknown* | 47,388 | 7.35p | Negotiated Trade |
16:35:00 - 18-Jul-25 |
Sell* | 1 | 7.00p | Ordinary |
16:28:00 - 18-Jul-25 |
Buy* | 40,000 | 7.30p | Ordinary |
15:35:36 - 18-Jul-25 |
Buy* | 37 | 7.50p | Ordinary |
13:58:21 - 18-Jul-25 |
Sell* | 20,000 | 7.125p | Ordinary |
12:58:51 - 18-Jul-25 |
Sell* | 1,870 | 7.00p | Ordinary |
11:51:54 - 18-Jul-25 |
Sell* | 813 | 7.00p | Ordinary |
09:23:47 - 18-Jul-25 |
Buy* | 4,000 | 8.00p | Ordinary |
09:07:57 - 18-Jul-25 |
Sell* | 1,500 | 7.00p | Ordinary |
08:29:59 - 18-Jul-25 |
Renalytix Plc (RENX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
17th Jul 2025 7:01 am | RNS | Partnership with MVP Health Care |
17th Jul 2025 7:00 am | RNS | Change of Adviser |
27th Jun 2025 1:09 pm | RNS | Holding(s) in Company |
26th Jun 2025 11:48 am | RNS | Holding(s) in Company |
17th Jun 2025 7:00 am | RNS | kidneyintelX.dkd data presented at ERA Congress |
3rd Jun 2025 7:00 am | RNS | Growing collaboration with NYKHM |
30th May 2025 12:38 pm | RNS | Holding(s) in Company |
29th May 2025 12:35 pm | RNS | Holding(s) in Company |
27th May 2025 12:43 pm | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | First use of KidneyIntelX in new CKD therapy trial |